GL1X · GenesisL1 explorer

Ligand · PS1

PS1 · 1,2-didecanoyl-sn-glycero-3-[phospho-L-serine]

PS1, 1,2-didecanoyl-sn-glycero-3-[phospho-L-serine] (C26 H49 N O10 P -1, 566.6 g/mol), in the MolNFT structures on GenesisL1: bound in 3 records (3 PDB entries). Every binding site with its residues within 4.5 Å, the residues it binds most…

Component
PS1
Formula
C26 H49 N O10 P -1
Class
ligand
Structures
3
PDB entries
3

Binding sites

PS1 in 3 structures; the first of them:

  • 8UO8 · Structure of synaptic vesicle protein 2B with padsevonil · PS1 A705 · binds HIS104, GLY105, ARG106, TRP109, ILE110, PHE113, LYS328
  • 8UO9 · Structure of synaptic vesicle protein 2A in complex with a nanobody · PS1 A803 · binds VAL633, ALA724, SER727, SER728, LEU731, LYS732
  • 8X90 · P/Q type calcium channel · PS1 A2601 · binds THR316, MET317, GLU318, PHE349, LEU352, THR665, GLY666, GLU667 and 16 more

Residues it binds most

PHE 2, LEU 2, THR 1, GLU 1, GLY 2, SER 2, VAL 2, ALA 2, LYS 2, MET 1 (residue and the binding sites it lines).

Found with

  • Y01 · Cholesterol hemisuccinate
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose
  • 3PE · 1,2-diacyl-sn-glycero-3-phosphoethanolamine
  • 43Y · [(2R)-3-[oxidanyl-[2-(trimethyl-$L^{4}-azanyl) ethoxy]phosphoryl]oxy-2-propanoyloxy-propyl] propanoate
  • 9Z9 · (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en
  • CLR · Cholesterol
  • PT5 · (1S)-2-{[(R)-hydroxy{[(1r,2r,3s,4r,5r,6s)-2,3,6-trihydroxy-4,5-bis(phosphonooxy) cyclohexyl]oxy}phosphoryl]oxy}-1-[(octadecanoyloxy) methyl]ethyl (8E,11E)-icosa-5,8,11,14-tetraenoate
  • X3U · (4R)-4-(2-chloro-2,2-difluoroethyl)-1-{[(4R)-2-(methoxymethyl)-6-(trifluoromethyl)imidazo[2,1-b][1,3,4]thiadiazol-5-yl]methyl}pyrrolidin-2-one
  • X49 · (4S)-1-{[(4S)-2-(methoxymethyl)-6-(trifluoromethyl)imidazo[2,1-b][1,3,4]thiadiazol-5-yl]methyl}-4-(4,4,4-trifluorobutyl)pyrrolidin-2-one
  • CA · Calcium ion
  • BMA · beta-D-mannopyranose

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.